Literature DB >> 32633852

Neuropathological profile of long-duration amyotrophic lateral sclerosis in military Veterans.

Keith R Spencer1, Zachariah W Foster1, Nazifa Abdul Rauf1, Latease Guilderson1, Derek Collins1, James G Averill2, Sean E Walker2, Ian Robey2, Jonathan D Cherry1,3,4, Victor E Alvarez1,3,5,6, Bertrand R Huber1,3,6, Ann C McKee1,3,5,6, Neil W Kowall1,3,5, Christopher B Brady1,5,7, Thor D Stein1,3,4,6.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting both the upper and lower motor neurons. Although ALS typically leads to death within 3 to 5 years after initial symptom onset, approximately 10% of patients with ALS live more than 10 years after symptom onset. We set out to determine similarities and differences in clinical presentation and neuropathology in persons with ALS with long vs. those with standard duration. Participants were United States military Veterans with a pathologically confirmed diagnosis of ALS (n = 179), dichotomized into standard duration (<10 years) and long-duration (≥10 years). The ALS Functional Rating Scale-Revised (ALSFRS-R) was administered at study entry and semi-annually thereafter until death. Microglial density was determined in a subset of participants. long-duration ALS occurred in 76 participants (42%) with a mean disease duration of 16.3 years (min/max = 10.1/42.2). Participants with long-duration ALS were younger at disease onset (P = 0.002), had a slower initial ALS symptom progression on the ALSFRS-R (P < 0.001) and took longer to diagnose (P < 0.002) than standard duration ALS. Pathologically, long-duration ALS was associated with less frequent TDP-43 pathology (P < 0.001). Upper motor neuron degeneration was similar; however, long-duration ALS participants had less severe lower motor neuron degeneration at death (P < 0.001). In addition, the density of microglia was decreased in the corticospinal tract (P = 0.017) and spinal cord anterior horn (P = 0.009) in long-duration ALS. Notably, many neuropathological markers of ALS were similar between the standard and long-duration groups and there was no difference in the frequency of known ALS genetic mutations. These findings suggest that the lower motor neuron system is relatively spared in long-duration ALS and that pathological progression is likely slowed by as yet unknown genetic and environmental modifiers. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  amyotrophic lateral sclerosis; long-duration; microglia; military Veterans; motor neuron disease; neuroinflammation; neuropathology; survival

Mesh:

Year:  2020        PMID: 32633852      PMCID: PMC8018169          DOI: 10.1111/bpa.12876

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  90 in total

Review 1.  Occurrence of amyotrophic lateral sclerosis among Gulf War veterans.

Authors:  R D Horner; K G Kamins; J R Feussner; S C Grambow; J Hoff-Lindquist; Y Harati; H Mitsumoto; R Pascuzzi; P S Spencer; R Tim; D Howard; T C Smith; M A K Ryan; C J Coffman; E J Kasarskis
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

3.  Factors associated with survival in the National Registry of Veterans with ALS.

Authors:  Daniel M Pastula; Cynthia J Coffman; Kelli D Allen; Eugene Z Oddone; Edward J Kasarskis; Jennifer H Lindquist; Joel C Morgenlander; Barbara B Norman; Marvin P Rozear; Laura A Sams; Arman Sabet; Richard S Bedlack
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

4.  Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.

Authors:  Yasushi Nishihira; Chun-Feng Tan; Osamu Onodera; Yasuko Toyoshima; Mitsunori Yamada; Takashi Morita; Masatoyo Nishizawa; Akiyoshi Kakita; Hitoshi Takahashi
Journal:  Acta Neuropathol       Date:  2008-05-15       Impact factor: 17.088

5.  Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis.

Authors:  D Nagy; T Kato; P D Kushner
Journal:  J Neurosci Res       Date:  1994-06-15       Impact factor: 4.164

6.  Integrated magnetic resonance imaging and [11 C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis.

Authors:  Mohamad J Alshikho; Nicole R Zürcher; Marco L Loggia; Paul Cernasov; Beverly Reynolds; Olivia Pijanowski; Daniel B Chonde; David Izquierdo Garcia; Caterina Mainero; Ciprian Catana; James Chan; Suma Babu; Sabrina Paganoni; Jacob M Hooker; Nazem Atassi
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

7.  Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy.

Authors:  Jonathan D Cherry; Yorghos Tripodis; Victor E Alvarez; Bertrand Huber; Patrick T Kiernan; Daniel H Daneshvar; Jesse Mez; Philip H Montenigro; Todd M Solomon; Michael L Alosco; Robert A Stern; Ann C McKee; Thor D Stein
Journal:  Acta Neuropathol Commun       Date:  2016-10-28       Impact factor: 7.801

Review 8.  Inflammation in ALS/FTD pathogenesis.

Authors:  Madelyn E McCauley; Robert H Baloh
Journal:  Acta Neuropathol       Date:  2018-11-21       Impact factor: 17.088

9.  Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy.

Authors:  Michael L Alosco; Thor D Stein; Yorghos Tripodis; Alicia S Chua; Neil W Kowall; Bertrand Russell Huber; Lee E Goldstein; Robert C Cantu; Douglas I Katz; Joseph N Palmisano; Brett Martin; Jonathan D Cherry; Ian Mahar; Ronald J Killiany; Michael D McClean; Rhoda Au; Victor Alvarez; Robert A Stern; Jesse Mez; Ann C McKee
Journal:  JAMA Neurol       Date:  2019-11-01       Impact factor: 18.302

10.  Molecular imaging of microglial activation in amyotrophic lateral sclerosis.

Authors:  Philippe Corcia; Clovis Tauber; Johnnie Vercoullie; Nicolas Arlicot; Caroline Prunier; Julien Praline; Guillaume Nicolas; Yann Venel; Caroline Hommet; Jean-Louis Baulieu; Jean-Philippe Cottier; Catherine Roussel; Mickael Kassiou; Denis Guilloteau; Maria-Joao Ribeiro
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  6 in total

Review 1.  Histamine-4 Receptor: Emerging Target for the Treatment of Neurological Diseases.

Authors:  Ling Shan; Gerard J M Martens; Dick F Swaab
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Utility of the ALSFRS-R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank.

Authors:  Leigh E Colvin; Zachariah W Foster; Thor D Stein; Manisha Thakore-James; Mohammad Kian Salajegheh; Kendall Carr; Keith R Spencer; Nazifa Abdul Rauf; Latease Adams; James G Averill; Sean E Walker; Ian Robey; Victor E Alvarez; Bertrand R Huber; Ann C McKee; Neil W Kowall; Christopher B Brady
Journal:  Muscle Nerve       Date:  2022-06-04       Impact factor: 3.852

3.  MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.

Authors:  Marcela Alvia; Nurgul Aytan; Keith R Spencer; Zachariah W Foster; Nazifa Abdul Rauf; Latease Guilderson; Ian Robey; James G Averill; Sean E Walker; Victor E Alvarez; Bertrand R Huber; Rebecca Mathais; Kerry A Cormier; Raymond Nicks; Morgan Pothast; Adam Labadorf; Filisia Agus; Michael L Alosco; Jesse Mez; Neil W Kowall; Ann C McKee; Christopher B Brady; Thor D Stein
Journal:  Front Neurosci       Date:  2022-05-19       Impact factor: 5.152

Review 4.  Neuroimaging and advanced research techniques may lead to improved outcomes in military members suffering from traumatic brain injury.

Authors:  Ron B Moyron; Paul A Vallejos; Ryan N Fuller; Natasha Dean; Nathan R Wall
Journal:  Trauma Surg Acute Care Open       Date:  2021-01-07

5.  Fast Progression in Amyotrophic Lateral Sclerosis Is Associated With Greater TDP-43 Burden in Spinal Cord.

Authors:  Sahara J Cathcart; Stanley H Appel; Leif E Peterson; Ericka P Greene; Suzanne Z Powell; Anithachristy S Arumanayagam; Andreana L Rivera; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-10       Impact factor: 3.685

6.  Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants.

Authors:  Sergi Borrego-Écija; Janina Turon-Sans; Teresa Ximelis; Iban Aldecoa; Laura Molina-Porcel; Mónica Povedano; Miguel Angel Rubio; Josep Gámez; Antonio Cano; Martí Paré-Curell; Lorena Bajo; Javier Sotoca; Jordi Clarimón; Mircea Balasa; Anna Antonell; Albert Lladó; Raquel Sánchez-Valle; Ricard Rojas-García; Ellen Gelpi
Journal:  Brain Pathol       Date:  2021-02-12       Impact factor: 6.508

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.